Nonverbal Communication in Aged People (MAMUS)

May 11, 2026 updated by: University Hospital, Lille

Nonverbal Communication in Aged People With and Without Neurodegenerative Disease: Study of Sensorimotor Synchronization to Music

Musical interventions improve the emotional state of patients with Alzheimer's disease (AD) while having a positive impact on the caregiver's well-being. However, the factors that could be responsible for this positive effect remain unknown. Among these, the sensory-motor synchronization (SMS) of movements to the musical rhythm, frequently observed during musical activities and possible up to the advanced stages of AD, could modulate the emotional state. Several recent studies have shown that rhythmic training (or SMS) influences the organism at the motor, cognitive and social levels while activating the cerebral reward circuit. This action that generates pleasure also facilitates non-verbal emotional expression. However, the conditions that modulate SMS and their relationship to nonverbal communication, emotional, behavioral and cognitive state have not yet been studied in healthy or pathological elderly.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

240

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lille, France
        • Hôpital les Bateliers, CHU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Cases : Patients with neurodegenerative disease (AD or related disease)

  • Native French Language
  • Corrected auditory and/or visual deficiency
  • Right-handed
  • Image rights consent signed by the patient Controls: People with no neuropathological disease
  • Native French Language
  • Corrected auditory and/or visual deficiency
  • Right-handed
  • Image rights consent signed by the control

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Patients with neurodegenerative disease
Patients with neurodegenerative disease (AD or related disease)
The SSM is measured with an innovative tool (Music Balance Board) developed at the University of Ghent (Belgium) and specially designed to record the movements of the elderly in a natural and comfortable position This chair is equipped with a tablet and sensors that record the movements of the hand and body during the SSM to a musical sequence. The analysis will focus on the difference between the participant's striking and the beat of the music measured using this chair.
Active Comparator: People with no neuropathological disease
The SSM is measured with an innovative tool (Music Balance Board) developed at the University of Ghent (Belgium) and specially designed to record the movements of the elderly in a natural and comfortable position This chair is equipped with a tablet and sensors that record the movements of the hand and body during the SSM to a musical sequence. The analysis will focus on the difference between the participant's striking and the beat of the music measured using this chair.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
measure of consistency (oppositive of variability)
Time Frame: Baseline, before SMS task

measure of consistency (oppositive of variability) of the response corresponding to the length of a vector going from 0 (bad) to 1(very good response).

This measure is completed by another measure of asynchrony.

Baseline, before SMS task
measure of asynchrony.
Time Frame: Baseline, before SMS task
The asynchrony assess the accuracy of the movements in ms. If the participant anticipated the tap relative to the musical beat, the value is negative, if the participant delayed the tap, the value is positive. A perfect tap is 0 in this case
Baseline, before SMS task

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of the Music Balance Board (cf. primary outcome) during music in the presence of a real experimenter
Time Frame: Baseline, before SMS task
measure the quantity of movements derived from the variation of weight on the sensors below the platform in millivolts (mV)
Baseline, before SMS task
Measurement of the Music Balance Board (cf. primary outcome) during music in the presence of a virtual experimenter;
Time Frame: after SMS task, an average after 45 min
measure the quantity of movements derived from the variation of weight on the sensors below the platform in millivolts (mV)
after SMS task, an average after 45 min
Measurement of the Music Balance Board (cf. primary outcome) during metronome in the presence of a real experimenter
Time Frame: after SMS task, an average after 45 min
measure the quantity of movements derived from the variation of weight on the sensors below the platform in millivolts (mV)
after SMS task, an average after 45 min
Measurement of the Music Balance Board (cf. primary outcome) during metronome in the presence of a virtual experimenter.
Time Frame: after SMS task, an average after 45 min
measure the quantity of movements derived from the variation of weight on the sensors below the platform in millivolts (mV)
after SMS task, an average after 45 min
Decoding of non-verbal behaviors during the synchronization task
Time Frame: after SMS task, an average after 45 min
Decoding of non-verbal behavior during the synchronization task (rhythmic movements of the head, lips and lower limbs, visual contact) in duration (duration of the behavior/duration of the Condition expressed in seconds) by blind evaluators in the membership group.
after SMS task, an average after 45 min
Intensity of body movements (quantity of motion)
Time Frame: after SMS task, an average after 45 min

Intensity of body movements (quantity of motion) recorded by the motion sensors connected to the chair on which the patient sits.

recorded during the SSM test and a filmed interview

after SMS task, an average after 45 min
STAI Anxiety Scale Score
Time Frame: through study completion, an average of 2 hours
The State-Trait Anxiety Inventory (STAI) is a self-questionnaire, developed by Spielberger (7) and validated in French. It has 20 questions, assessing the subject's usual emotional state. A score is calculated, ranging from 20 to 80, a high score indicating the presence of anxiety.
through study completion, an average of 2 hours
Decoding of the frequency (number of behaviors / duration of the condition) of the facial expressions
Time Frame: through study completion, an average of 2 hours
the facial expressions based on videoscopic recordings of the synchronization task and a short interview (5min) by blind evaluators of the home group.
through study completion, an average of 2 hours
Scale of Assessment of Daily Activities
Time Frame: through study completion, an average of 2 hours
The ADLs used measure of functional ability is the Katz Activities of Daily Living Scale (Katz et al., 1963; Katx, 1983). In this scale, the set of tasks assessed are bathing, dressing, transferring, using the toilet, continence, and eating.
through study completion, an average of 2 hours
Scale of Instrumental Activities of Daily Living
Time Frame: through study completion, an average of 2 hours
The Lawton IADL Scale takes approximately 10 to 15 minutes to administer. It contains 8 items that are rated with a summary score from 0 (low functioning) to 8 (high functioning)
through study completion, an average of 2 hours
Neuropsychiatric Inventory (NPI) subscales Impact on the workload of the caregiver.
Time Frame: through study completion, an average of 2 hours
total NPI score is defined as the sum of the individual category scores. Higher scores on NPI indicate a more frequent and/or severe presence of neuropsychiatric behavioral changes. The following domains will be included in the subscore: Depression/Dysphoria, Anxiety, Apathy/Indifference, Irritability/Lability, Agitation/Aggression, and Disinhibition.
through study completion, an average of 2 hours
mini-mental state examination (MMSE) score
Time Frame: through study completion, an average of 2 hours

The Mini-Mental State Examination (MMSE) is a brief 30-point questionnaire test that is used to screen for cognitive impairment.

Scores on a scale range from 0 - 30. Scores 23 and below are indicative of problems.

through study completion, an average of 2 hours
Concentration of cortisol from saliva samples
Time Frame: Once, at Day 1, baseline
measure the saliva cortisol before and after the synchronization task
Once, at Day 1, baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: François Puissieux, MD,PhD, University Hospital, Lille

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 17, 2018

Primary Completion (Actual)

February 23, 2024

Study Completion (Actual)

February 23, 2024

Study Registration Dates

First Submitted

January 9, 2019

First Submitted That Met QC Criteria

October 30, 2019

First Posted (Actual)

October 31, 2019

Study Record Updates

Last Update Posted (Actual)

May 14, 2026

Last Update Submitted That Met QC Criteria

May 11, 2026

Last Verified

November 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alzheimer Disease

Clinical Trials on Music Balance Board

Subscribe